Cathie Wood Bets $90M on Anthropic Shares Across 6 ARK Funds, Sells Crypto ETFs, Nvidia

Cathie Wood Bets $90M on Anthropic Shares Across 6 ARK Funds, Sells Crypto ETFs, Nvidia


ARK Investment Management bought 934,968 shares of Anthropic (NASDAQ: ANT) across all six of its actively managed ETFs on November 19, the AI company’s first day of public trading, according to the firm’s daily trade notification.

The purchases covered ARK Innovation ETF (ARKK), ARK Next Generation Internet ETF (ARKW), ARK Autonomous Technology & Robotics ETF (ARKQ), ARK Genomic Revolution ETF (ARKG), ARK Fintech Innovation ETF (ARKF), and ARK Space Exploration & Innovation ETF (ARKX). 

ARK Investment Management added 934,968 Anthropic shares across all six active ETFs on debut.

ARK trimmed staking exposure, selling 425,000 Ether and 200,000 Solana ETF shares via ARKW and ARKF.

ARK reduced Nvidia holdings, offloading 33,430 shares through ARKQ while previously cutting larger positions.

The same notification recorded sales of 425,000 shares of the 3iQ Ether Staking ETF (ETHQ.U), 200,000 shares of the 3iQ Solana Staking ETF (SOLQ.U), and 33,430 Nvidia (NVDA) shares. The crypto ETF sales were split between ARKW and ARKF, while the Nvidia reduction came through ARKQ.

The trades show ARK adding Anthropic exposure while reducing positions in selected crypto-linked products and Nvidia. However, ARK’s disclosure does not establish that the sales directly financed the Anthropic purchases or explain the investment rationale behind any transaction.

ARK Buys Anthropic Across All Six Active ETFs

ARKK accounted for the largest share of the Anthropic purchase, adding 556,777 ANT shares, equivalent to 0.4190% of the fund’s total assets in the trade notification.

The other purchases were distributed as follows:

  • ARKW: 146,183 ANT shares, or 0.4828% of the ETF.
  • ARKQ: 90,923 ANT shares, or 0.4748% of the ETF.
  • ARKG: 77,782 ANT shares, or 0.4089% of the ETF.
  • ARKF: 38,729 ANT shares, or 0.5171% of the ETF.
  • ARKX: 24,574 ANT shares, or 0.3943% of the ETF.

The six transactions total 934,968 shares. The percentages in ARK’s notification represent the reported trade size relative to each ETF, not the resulting portfolio weight of Anthropic.

ARK’s notification does not disclose the prices at which the shares were purchased. At ANT’s November 19 closing price of $97.17, the combined share count would have had a market value of almost $90.9 million. That is a closing-price valuation of the shares acquired, not a confirmed figure for ARK’s purchase cost.

Anthropic Shares Close at $97.17 After Debut

ARK’s purchases came as Anthropic began trading on the Nasdaq under the ticker ANT on November 19, following an $83-per-share IPO.

The stock opened at $111.50, approximately 34% above its offering price, before retreating during the session to close at $97.17, still around 17% above the IPO price. Nasdaq confirmed the opening trade in its listing announcement.

Anthropic had priced its IPO on November 18, offering 980 million Class A shares. The company said 956,351,354 shares were being sold by Anthropic and 23,648,646 by existing stockholders. The offering was expected to close on November 20, subject to customary conditions, according to the company’s official pricing announcement.

The first-day close also landed close to a price indicated by crypto derivatives before the listing. As The Crypto Times reported, on-chain perpetual futures priced Anthropic at $97.22 on November 17, two days before the IPO. ANT’s $97.17 close was just five cents below that reading, although the stock’s opening price was substantially higher.

The comparison is notable but does not establish that crypto traders predicted the closing price. The derivatives reading was recorded at a different time and in a separate market, with different liquidity and contract characteristics.

ARK Trims Ether and Solana Staking ETF Positions

The crypto-linked sales were concentrated in ARKW and ARKF.

Through ARKW, ARK sold 281,318 shares of the 3iQ Ether Staking ETF and 122,069 shares of the 3iQ Solana Staking ETF. The transactions represented 0.0652% and 0.0248% of the respective ETF’s total assets, according to the notification.

ARKF sold another 143,682 ETHQ.U shares and 77,931 SOLQ.U shares, representing 0.1344% and 0.0638% of that fund, respectively.

Across both ETFs, the sales totalled 425,000 Ether staking ETF shares and 200,000 Solana staking ETF shares.

These were reductions in ETF positions providing exposure to staking-related products, not direct sales of ETH or SOL tokens. The notification does not disclose the sale prices or the value of the transactions.

The move follows other recent changes in ARK’s crypto-related holdings. On November 16, the firm sold a combined 543,092 Nvidia shares while buying SpaceX, Coinbase, Circle and Block shares. It also reduced its holdings in the same 3iQ Ether and Solana staking ETFs and sold shares of crypto exchange operator Bullish.

The November 19 transactions extend that pattern of adjustments in the staking ETFs, but do not by themselves establish a broader retreat from crypto markets.

Nvidia Sale Continues Recent Position Reduction

ARKQ sold 33,430 Nvidia shares on November 19, equivalent to 0.2629% of the ETF’s total assets in the trade notification.

The sale followed ARK’s larger Nvidia reduction three days earlier, when the firm sold 543,092 shares across ARKK and ARKW. That November 16 session also included purchases of 378,515 SpaceX shares and additional positions in Coinbase, Circle and Block.

ARK’s recent Nvidia activity has not been one-directional. The firm bought 90,443 Nvidia shares on November 9 across five ETFs before making the larger reduction on November 16. The November 19 sale represents another disclosed reduction, but ARK’s daily trade files do not explain whether the transactions were linked to a change in its assessment of Nvidia.

Other Trades Across ARK’s Portfolio

The November 19 notification also showed purchases and sales outside Anthropic, Nvidia, and crypto-linked ETFs.

ARKQ bought 882,530 shares of Kodiak AI, while ARKG added 18,151 shares of Twist Bioscience. ARKG also sold 28,095 CareDx shares, 93,430 Adaptive Biotechnologies shares and 2,094 Eli Lilly shares.

ARKX sold 2,134 shares of HEICO and 2,803 shares of Garmin. The notification also recorded the purchases of Anthropic shares through ARKF and ARKX, completing the six-fund exposure.

The transactions indicate that ARK made adjustments across AI, biotechnology, aerospace and digital-asset-related holdings during the session, rather than concentrating all activity in Anthropic.

ARK’s Trade Disclosures Carry Important Limitations

ARK says its daily trade notifications reflect portfolio adjustments made by its investment team, but are not comprehensive records of all activity in its ETFs. They exclude ETF creation and redemption activity and may be supplemented by additional files.

The firm also describes the notifications as unofficial and unreconciled. Its official accounting and custody processes are handled by BNY Mellon, which produces the ETFs’ daily net asset values. The notifications do not provide transaction prices or explain the reasoning behind individual trades.

ARK further states that the notifications are for informational purposes and are not recommendations to buy, sell or hold any security.

The November 19 activity therefore confirms that ARK added Anthropic across its six actively managed ETFs while reducing selected staking ETF and Nvidia positions. It does not establish the exact amount spent on ANT, whether the sales funded the purchases, or whether the transactions signal a longer-term shift in the firm’s investment strategy.

Also Read: Binance Wallet to Refund 500M USDC After Anthropic IPO Allocation Issues


Disclaimer: The information researched and reported by The Crypto Times is for informational purposes only and is not a substitute for professional financial advice. Investing in crypto assets involves significant risk due to market volatility. Always Do Your Own Research (DYOR) and consult with a qualified Financial Advisor before making any investment decisions.





Leave a Reply

Your email address will not be published. Required fields are marked *